Professor of Bioethics in the Faculty of Medicine at the University of Geneva
Pro to the question "Should Performance Enhancing Drugs (Such as Steroids) Be Accepted in Sports?"
"We believe that rather than drive doping underground, use of drugs should be permitted under medical supervision.
Legalisation of the use of drugs in sport might even have some advantages. The boundary between the therapeutic and ergogenic - ie, performance enhancing - use of drugs is blurred at present and poses difficult questions for the controlling bodies of antidoping practice and for sports doctors. The antidoping rules often lead to complicated and costly administrative and medical follow-up to ascertain whether drugs taken by athletes are legitimate therapeutic agents or illicit.
...Furthermore, legalisation of doping, we believe, would encourage more sensible, informed use of drugs in amateur sport, leading to an overall decline in the rate of health problems associated with doping. Finally, by allowing medically supervised doping, the drugs used could be assessed for a clearer view of what is dangerous and what is not...
Acknowledging the importance of rules in sports, which might include the prohibition of doping, is, in itself, not problematic. However, a problem arises when the application of these rules is beset with diminishing returns: escalating costs and questionable effectiveness."
"Viewpoint: Legalisation of Performance-Enhancing Drugs," The Lancet, Dec. 2005
Experts Individuals with MDs, JDs, PhDs, or equivalent advanced degrees in fields relevant to performance enhancing drugs and sports. Also top-level government officials (such as foreign leaders, US presidents, Founding Fathers, Supreme Court Justices, members of legislative bodies, cabinet members, military leaders, etc.) with positions relevant to performance enhancing drugs and sports.
Involvement and Affiliations:
Professor of Bioethics, Faculty of Medicine, University of Geneva, 1995-present
Member, Swiss Science and Technology Council (SSTC), 2004-present
Member, Swiss Academy of Medical Sciences
Former member, National Ethics Commission in Human Medicine NEK-CEN and the Ethics Committee for Research at the World Health Organization (WHO)
Former Scientific Advisor, Fondation Louis-Jeantet de Médecine, Geneva
Completed post-doctoral studies at Stanford University and the Institute for Biochemistry at the University of Geneva
PhD, Molecular Biology, University of Lausanne, 1978
Phone: 41-22-379-34-71 Fax: 41-22-37934-72 Email:[email protected] Website: None found
Coedited with Bernice Elger, Nikola Biller-Andorno, and Alexander M. Capron, Ethical and Regulatory Aspects of Human Genetic Databases, 2008
Cowritten with Bengt Kayser, MD, PhD, and Andy Miah, PhD, "Viewpoint: Legalisation of Performance-Enhancing Drugs," The Lancet, Dec. 2005